IP Library › Assignment 074028/0972
Patent Assignment
Reel/Frame 074028/0972

Assignment of Assignor's Interest

Recorded: 2025-12-22 Pages: 9
Assignor
VOR BIOPHARMA, INC.
Executed: 2025-08-08
Assignee
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NEW YORK, 10591
Covered Properties (76)
Methods for Treating Autoimmune Diseases
Application: 19/312,214 →
Anti-CD45-Ign Antibody Drug Conjugates and Uses Thereof
Application: 19/085,767 →
Therapeutic Methods Using Antibody Drug Conjugates (Adcs)
Application: 19/067,310 →
Publication: US 2026/0014202
Compositions and Methods for the Depletion of Cells
Application: 18/605,123 →
Publication: US 2024/0408168
Compositions and Methods for Allogeneic Transplantation
Application: 17/820,540 →
Publication: US 2023/0390412
Methods of Use of Anti-CD45 Antibodies and Conjugates Thereof
Application: 17/452,028 →
Publication: US 2022/0267441
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
Application: 17/508,641 →
Publication: US 2022/0175951
Conditioning Methods for Gene Therapy
Application: 17/507,456 →
Publication: US 2022/0175946
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Application: 17/368,815 →
Publication: US 2022/0062339
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 17/244,864 →
Publication: US 2021/0379195
Fc Silenced Antibodies and Antibody Drug Conjugates (Adcs)
Application: 16/863,948 →
Publication: US 2020/0255523
Compositions and Methods for the Depletion of Endogenous Hematopoietic Stem Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/351,725 →
Compositions and Methods for the Depletion of Endogenous CD135+ Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/351,778 →
Compositions and Methods for the Depletion of Endogenous Hematopoietic Stem Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/437,729 →
Compositions and Methods for the Depletion of Endogenous CD135+ Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/437,756 →
Compositions and Methods for the Depletion of Endogenous CD135+ Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/448,768 →
Compositions and Methods for the Depletion of Endogenous Hematopoietic Stem Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/448,782 →
THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCs)
Application: 62/682,154 →
Fc Silenced Antibody Drug Conjugates (Adcs) and Uses Thereof
Application: 62/749,662 →
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 62/752,828 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/753,002 →
THERAPEUTIC METHODS USING ANTI-CD117 ANTIBODY DRUG CONJUGATES (ADCs)
Application: 62/773,839 →
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 62/773,873 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/774,006 →
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Application: 62/789,462 →
THERAPEUTIC METHODS USING ANTI-CD117 ANTIBODY DRUG CONJUGATES (ADCs)
Application: 62/807,363 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/807,582 →
Conditioning Methods for Gene Therapy
Application: 62/838,278 →
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
Application: 62/838,280 →
Therapeutic Methods Using Antibody Drug Conjugates (Adcs)
Application: 62/841,702 →
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Application: 62/845,829 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/857,232 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/863,141 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/882,310 →
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 62/882,362 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,137 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,194 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,207 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,283 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,288 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,347 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/929,601 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/933,279 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/940,742 →
Conditioning Methods for Gene Therapy
Application: 62/944,925 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/944,988 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/968,870 →
Compositions and Methods for Allogeneic Transplantation
Application: 62/978,141 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/978,147 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 63/015,348 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 63/030,860 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 63/046,046 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 63/046,164 →
Compositions and Methods for Allogeneic Transplantation
Application: 63/062,845 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 63/084,903 →
Anti-CD45-Ign Antibody Drug Conjugates and Uses Thereof
Application: 63/376,435 →
Anti-CD45-Ign Antibody Drug Conjugates and Uses Thereof
Application: 63/483,923 →
ANTI-CD45-IGN Antibody Drug Conjugates and Uses Thereof
Application: 63/485,200 →
ANTI-CD45-IGN Antibody Drug Conjugates and Uses Thereof
Application: 63/499,340 →
Anti-CD45 Antibody-Drug Conjugate Pharmaceutical Compositions
Application: 63/584,107 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 18/598,342 →
Publication: US 2024/0254251
Anti-CD45 Antibodies and Conjugates Thereof
Application: 17/244,856 →
Publication: US 2021/0371524
Methods and Compositions for Treating Autoimmune Diseases
Application: 17/457,583 →
Publication: US 2022/0273811
Methods for the Depletion of Cells
Application: 16/289,388 →
Publication: US 2019/0192682
Compositions and Methods for the Depletion of Cells
Fc Silenced Antibody Drug Conjugates (Adcs) and Uses Thereof
Anti-CD45 Antibodies and Conjugates Thereof
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
Conditioning Methods for Gene Therapy
Methods and Compositions for Treating Autoimmune Diseases
Anti-CD45 Antibodies and Conjugates Thereof
Compositions and Methods for Allogeneic Transplantation
Title Not Available
Anti-CD45 Antibody-Drug Conjugate Pharmaceutical Compositions
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 23, 2018
From: NIXON, ANDREW; MORROW, DWIGHT; HARTIGAN, ADAM
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 045322/0857 →
Assignment of Assignor's Interest Mar 23, 2018
From: NIXON, ANDREW; MORROW, DWIGHT; HARTIGAN, ADAM
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 045322/0976 →
Assignment of Assignor's Interest Apr 9, 2019
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048838/0161 →
Assignment of Assignor's Interest Apr 9, 2019
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048838/0178 →
Assignment of Assignor's Interest Apr 9, 2019
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048838/0188 →
Assignment of Assignor's Interest Apr 9, 2019
From: PEARSE, BRADLEY R.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048838/0199 →
Assignment of Assignor's Interest Jun 5, 2019
From: BOITANO, ANTHONY; COOKE, MICHAEL; PROCTOR, JENNIFER LYNN; MCDONAGH, CHARLOTTE FENTON
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 049386/0340 →
Assignment of Assignor's Interest Jun 5, 2019
From: COOKE, MICHAEL; PROCTOR, JENNIFER LYNN; MCDONAGH, CHARLOTTE FENTON
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 049386/0328 →
Assignment of Assignor's Interest Oct 23, 2019
From: BOITANO, ANTHONY; COOKE, MICHAEL; MCDONAGH, CHARLOTTE FENTON; PEARSE, BRADLEY R.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050806/0847 →
Assignment of Assignor's Interest Oct 23, 2019
From: BOITANO, ANTHONY; COOKE, MICHAEL; MCDONAGH, CHARLOTTE FENTON; PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050806/0839 →
Assignment of Assignor's Interest Oct 23, 2019
From: BOITANO, ANTHONY; COOKE, MICHAEL; MCDONAGH, CHARLOTTE FENTON; PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050806/0834 →
Assignment of Assignor's Interest Oct 30, 2019
From: PALCHAUDHURI, RAHUL; PEARSE, BRADLEY R.; ADAMS, HILLARY; MCDONOUGH, SEAN
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050869/0083 →
Assignment of Assignor's Interest Oct 30, 2019
From: PALCHAUDHURI, RAHUL; PROCTOR, JENNIFER LYNN; GILLARD, GEOFFREY O.; BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050869/0374 →
Assignment of Assignor's Interest Oct 31, 2019
From: GIRAFPHARMA LLC
To: NUVATION BIO INC.
Reel/Frame 050884/0853 →
Assignment of Assignor's Interest Jan 7, 2020
From: GILLARD, GEOFFREY O.; BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 051438/0417 →
Assignment of Assignor's Interest Apr 13, 2020
From: MCDONAGH, CHARLOTTE FENTON
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052384/0304 →
Assignment of Assignor's Interest Apr 20, 2020
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052447/0746 →
Assignment of Assignor's Interest Apr 21, 2020
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052458/0586 →
Assignment of Assignor's Interest Apr 22, 2020
From: PEARSE, BRADLEY R.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052468/0304 →
Assignment of Assignor's Interest Apr 23, 2020
From: GILLARD, GEOFFREY O.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0325 →
Assignment of Assignor's Interest Apr 23, 2020
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0288 →
Assignment of Assignor's Interest Apr 23, 2020
From: PEARSE, BRADLEY R.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0487 →
Assignment of Assignor's Interest Apr 23, 2020
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0556 →
Assignment of Assignor's Interest Apr 24, 2020
From: COOKE, MICHAEL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052487/0411 →
Assignment of Assignor's Interest Jun 2, 2020
From: GILLARD, GEOFFREY O.; PROCTOR, JENNIFER LYNN; BOITANO, ANTHONY; COOKE, MICHAEL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052817/0594 →